Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
5SZnay2QmkdmcWR3